Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06085326

Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

The purpose of the study is to implement a patient-provider dyad tailored, Electronic Health Record (EHR)-informed, digitized Smart Checklist as a Quality Improvement (QI) intervention to support bedside clinician teams to reduce Adverse Airway Outcomes (AAO) across 6 diverse pediatric intensive care units (ICUs).

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 19 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Arkansas, Little Rock, Arkansas, United States

Loading trial locations.

About this study

More than 20% of the critically ill children who require tracheal intubation suffer from adverse events. To reduce the adverse event risk, and optimize bedside team performance investigators will implement a digitized Smart Checklist that has three specific features: (1) prompts based on patient characteristics, (2) direct display of difficult airway status and airway information, and (3) high-risk warning based on predictive analytics.

This is a stepped-wedge cluster randomized trial of PICU patients who are intubated across 6 participating hospitals to determine if the Smart Checklist reduces the incidence of adverse tracheal intubation associated events.

The primary objective of this study is to determine the clinical impact of the personalized, dynamic, adaptive Smart Checklist implementation on the occurrence of Adverse Airway Outcomes (AAOs) in the pediatric ICU. The secondary objective is to characterize work systems and processes that affect clinical impact of the digitized Smart Checklist.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients intubated in the PICU at participating sites

Exclusion criteria

Endotracheal tube exchanges, as this represents a distinct procedure

Treatment and study plan

Smart Checklist

Other

The digitized Smart Checklist includes three new features that currently do not exist on a paper checklist: 1) decision support prompts based on patient-provider dyad characteristics, 2) real time display of patient pertinent airway information from the EHR, and 3) high-risk warning alerts based on predictive analytics with potential explanatory factors from the model.

Primary outcomes

  1. Adverse Airway Outcomes

    Time frame: During the intubation procedure and up to 20 minutes after procedure

    A composite outcome for adverse events or acute oxygen desaturation <80%

Secondary outcomes

  1. Duration of invasive mechanical ventilation

    Time frame: During the ICU stay, up to 180 days

    Duration of invasive mechanical ventilation (time to extubation or tracheostomy)

  2. Duration of ICU stay

    Time frame: During the ICU stay, up to 180 days

    Duration of ICU stay (days)

  3. ICU mortality

    Time frame: During the ICU stay, up to 180 days

    ICU mortality (all cause)

Study contacts

Contact information is provided by the study sponsor or research team.

Akira Nishisaki, MD, MSCE

CONTACT

[email protected]

215-590-1000

Hayley Buffman, MPH

CONTACT

[email protected]

215-590-1000

Sponsors and collaborators

Lead sponsor

Children's Hospital of Philadelphia

Other

Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

Registry information

Acronym: SMART PICU

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
Oct 16, 2023
Registry last updated
Oct 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.